Production of Biologically Derived Small Molecule Regulatory Starting Materials and/or Active Pharmaceutical Ingredients at Commercial Scale

Through these BioMaP-Consortium awards, ASPR IBMSC is partnering with the awardees listed below to develop a biological design-build-test cycle for the production of small molecule drug substances at commercial scale. This supports ASPR IBMSC’s broader long-term goal of developing and commercializing infrastructure that will be accessible to a broad community of Users for the purpose of producing drug substances, creating a new manufacturing paradigm that can be competitive in the global market and to onshore drug production.